Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guju Pharm is a South Korean pharmaceutical company established in 1974, specializing in the development and manufacture of ethical (ETC) and over-the-counter (OTC) medicines. The company is best known for "Apitoxin," the first natural substance-based new drug in Korea, which is a purified bee venom injection used for treating osteoarthritis. Guju Pharm maintains a diverse portfolio covering musculoskeletal, circulatory, respiratory, and digestive therapeutic areas. With a strong focus on R&D and GMP-certified manufacturing facilities, the company provides a wide range of treatments including anti-inflammatory drugs, antibiotics, and nutritional supplements to the domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guju Pharm.